Mallinckrodt Loses $9.5M Award But Wins Delay In Airgas Drug
A Delaware federal judge on Tuesday threw out Mallinckrodt Pharmaceuticals' $9.5 million jury award it won in an infringement case and instead blocked a competitor's inhaled nitric oxide treatment patent until...To view the full article, register now.
Already a subscriber? Click here to view full article